BUY Glenmark Pharmaceuticals — Manas Jaiswal
Glenmark Pharmaceuticals share price target & all analyst calls
byManas JaiswalHorizon: NA (inferred Intraday)28 Aug 2026, 2:20 pm ISTvia CNBC Awaaz.
Entry₹2,493Inferred
Stop loss₹2,459-1.36% risk
At expiry₹2,513.728 Aug 2026, 3:05 pm
Expired+0.83%
Follow Manas Jaiswal for new calls(11% target hit, 148 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alerts
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
0 supporting1 neutral0 opposing
Supports the BUY call (0)
Nothing found in this tip’s window yet.
Neutral / worth noting (1)
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Glenmark Pharmaceuticals
- BUY — Prakash Gaba21 Oct 2026 · Same day · target ₹2,300 · SL hit
- BUY — Somil Mehta, Sharekhan19 Oct 2026 · ~2 weeks · target ₹2,400 · SL hit
- BUY — Osho Krishan, Angel One13 Oct 2026 · ~2 weeks · target ₹2,400 · Active
- BUY — Manas Jaiswal9 Oct 2026 · ~2 weeks · target ₹2,375 · SL hit
- BUY — Prakash Gaba9 Oct 2026 · ~2 weeks · target ₹2,350 · SL hit
More from Manas Jaiswal
- BUY Ajanta Pharma23 Oct 2026 · Same day · target ₹3,425 · SL hit
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · SL hit
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active